Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
32 studies found for:    "Encephalitis, Tick-Borne"
Show Display Options
Rank Status Study
21 Completed Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
22 Completed Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years
Condition: Encephalitis, Tick-Borne
Intervention: Procedure: blood draw
23 Completed FSME IMMUN NEW Follow-Up to Study 199 in Children Aged 1 to 6 Years
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
24 Completed Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Tick-Borne Encephalitis vaccine
25 Completed Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Tick-Borne Encephalitis vaccine
26 Completed Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl
27 Unknown  Postencephalitic Symptoms After Tick Borne Encephalitis
Condition: Central European Encephalitis
Intervention:
28 Completed Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years
Condition: Tick-Borne Encephalitis
Intervention: Biological: FSME-IMMUN NEW 0.25 ml
29 Completed Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years
Condition: Tick-Borne Encephalitis
Intervention: Biological: FSME-IMMUN 0.5ml
30 Completed Dose-Finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.
Condition: Tick-Borne Encephalitis
Intervention: Biological: Tick-borne encephalitis vaccine
31 Completed Dose-Finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.
Condition: Tick-Borne Encephalitis
Intervention: Biological: Tick-borne Encephalitis Vaccine
32 Completed Influence of Persistent CMV-infection on Immune Senescence
Condition: Immune Senescence
Intervention: Biological: Vaccination against TBEV (FSME Immun CC)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-32) Next Page   
Indicates status has not been verified in more than two years